Harmony of operations of some vitamins in controlling the 2019-nCoV virus based on scientific reports -

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 248

This Paper With 5 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_CHRL-3-4_007

تاریخ نمایه سازی: 17 فروردین 1400

Abstract:

Unlike other related compounds, vitamin D has multi-function operations against 2019-nCoV virus via intervention in several parts of its lifecycle. In one hand, this compound induces antimicrobial peptides like cathelicidins and proteins like defensins that lead to lower viral replication rates and also reduces the concentrations of pro-inflammatory cytokines (it causes inflammation that results in multi-organ failure). In the other hand, a vitamin D agonist, calcitriol, modulates the expression of members of the renin‑angiotensin system, including angiotensin converting enzymes like ACE2 (the cell receptor for 2019-nCoV viral spike protein). Thus, vitamin D may reduce the spike rate of the virus to the lung cells, resulting in inhibition of the virus in entry stage. About vitamin B series, there is a report that claims vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the 2019-nCoV virus.‏Also, vitamins C, and E (anti-oxidants with anti-inflammatory effects) could be effective in inhibiting the damages of the organs caused by the acute immune response (inhibiting the release of high concentrations of free radicals) during COVID-19 as well as boosting the human immune system. It must be mentioned that, in spite of the presented supporting references, this paper is prepared for researcher, not for all people.

Authors

Seyyed Amir Siadati

Department of Chemistry, Qaemshahr Branch, Islamic Azad University, Qaemshahr, Iran

Mohammad Amin Rezvanfar

Department of Toxicology and Pharmacology, Faculty of Pharmacy, and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran

Esmaeil Babanezhad

Department of Environmental Health, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran

Abolghasem Beheshti

Department of Chemistry, Payame Noor University, Tehran, Iran

Meghdad Payab

R&D Department, Quality Control Laboratories, Tofigh Daru Research and Engineering Company, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • [1] R. H. Britten, The incidence of epidemic influenza, 1918-19. ...
  • [2] Y. S. Malik, S. Sircar, S. Bhat, K. Sharun, ...
  • [3] M. A. Alamri, M. T. Qamar, S. F. Alqahtani, ...
  • [4] K. Bagherzadeh, K. Daneshvarnejad, M. Abbasinazari, In silico Repositioning ...
  • [5] V. Yethindra, Role of GS-5734 (Remdesivir) in inhibiting SARS-CoV ...
  • [6] L. Dong, S. Hu, J. Gao, Discovering drugs to ...
  • [7] a) S. A. Siadati, M. Afzali, M. Sayyadi, Could ...
  • b) O.. Zachar, Formulations for COVID-19 Early Stage Treatment via ...
  • c) M. Patel, Antimicrobial Paper Embedded with Nanoparticles as Spread-Breaker ...
  • d) M. Patel, Nanoparticle-based antimicrobial paper as spread-breaker for corona ...
  • [8] A. Casadevall, L. A. Pirofski, The convalescent sera option ...
  • [9] N. Narayanan, D. T. Nair, Vitamin B12 May Inhibit ...
  • [10] [10] R. Jayawardena, P. Sooriyaarachchi, M. Chourdakis, C. Jeewandara, ...
  • [11] S. Roy, A. Awasthi, Vitamin A and the Immune ...
  • [12] C. Stephensen, Z. Moldoveanu, N. N. Gangopadhyay, Vitamin A ...
  • [13] Z. Y. Peng, Vitamin C Infusion for the Treatment ...
  • https://clinicaltrials.gov/ct2/show/NCT04264533, phase 2 of ...
  • clinical trial (2020). ...
  • [14] R. Gupta, A. Ghosh, A. K. Singh, A. Misra, ...
  • [15] A. Erol, High-dose Intravenous Vitamin C Treatment for COVID-19–A ...
  • [16] World Health Organization. WHO R&D Blueprint: informal consultation on ...
  • [17] L. S. Wang, Y. R. Wang, D. W. Ye, ...
  • [18] M. Hoffmann, H. Kleine-Weber, N. Krüger, M. A. Mueller, ...
  • [19] J. Xu, J. Yang, J. Chen, Q. Luo, Q. ...
  • [20] W. B. Grant, H. Lahore, S. L. McDonnell, C. ...
  • [21] Ilie PC, Stefanescu S, Smith L. The role of ...
  • [22] M. Braiman, Latitude Dependence of the COVID-19 Mortality Rate—A ...
  • [23] M. Alipio, Vitamin D Supplementation Could Possibly Improve Clinical ...
  • [24] H. Hemila, Vitamin C intake and susceptibility to pneumonia. ...
  • [25] D. M. McCartney, D. G. Byrne, Optimisation of Vitamin ...
  • [26] M. Heinonen, V. Piironen, The tocopherol, tocotrienol, and vitamin ...
  • [27] J. Z. Wang, R. Y. Zhang, J. Bai, An ...
  • [28] N. Erol, L. Saglam, Y. S. Saglam, H. S. ...
  • [29] P. K. Law, Emergent Serum Therapy and Antibody Medicine ...
  • [30] A. Fischer, G. Rimbach, Gene Regulatory Activity of Vitamin ...
  • نمایش کامل مراجع